Category : Science and TechPublished on: October 30 2024
Share on facebook
Scientists at Pune’s Agharkar Research Institute developed non-toxic molecules targeting cholinesterase enzymes to improve acetylcholine levels, aiding in Alzheimer’s treatment.
Using synthetic, computational, and in vitro methods, researchers achieved a rapid, high-yield synthesis of molecules to address Alzheimer’s, the most prevalent form of dementia globally.